Trials / Conditions / Philadelphia Chromosome Negative Chronic Myelogenous Leukemia
Philadelphia Chromosome Negative Chronic Myelogenous Leukemia
3 registered clinical trials studyying Philadelphia Chromosome Negative Chronic Myelogenous Leukemia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Trans NCT01427881 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | 3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, NCT00381550 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer NCT00357708 | National Cancer Institute (NCI) | Phase 1 |